CHELSEA ALLAN: Open Payments
NPI 1669971412 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 12 payments from 8 companies in 2025. Trend: 2023 $188 · 2024 $853 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $163 |
| ABBVIE INC. | 3 | $79 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Medtronic, Inc. | 1 | $27 |
| Radius Health, Inc. | 1 | $25 |
| Indivior Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: ABILIFY MAINTENA, ABILIFY ASIMTUFII, VRAYLAR, VOQUEZNA, PROPEL, QULIPTA, Tymlos, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
